In vivo C6 glioma models: an update and a guide toward a more effective preclinical evaluation of potential anti-glioblastoma drugs

References

Akter, F., Simon, B., de Boer, N.L., Redjal, N., Wakimoto, H., and Shah, K. (2021). Pre-clinical tumor models of primary brain tumors: challenges and opportunities. Biochim. Biophys. Acta Rev. Cancer 1875: 188458, https://doi.org/10.1016/j.bbcan.2020.188458.Suche in Google Scholar PubMed PubMed Central

Amberger, V.R., Hensel, T., Ogata, N., and Schwab, M. (1998). Spreading and migration of human glioma and rat C6 cells on central nervous system myelin in vitro is correlated with tumor malignancy and involves a metalloproteolytic activity. Cancer Res. 58: 149–158.Suche in Google Scholar

Arrieta, O., Guevara, P., Escobar, E., García-Navarrete, R., Pineda, B., and Sotelo, J. (2005). Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma. Br. J. Cancer 92: 1247–1252, https://doi.org/10.1038/sj.bjc.6602483.Suche in Google Scholar PubMed PubMed Central

Arrieta, O., Guevara, P., Reyes, S., Palencia, G., Rivera, E., and Sotelo, J. (2001). Paradoxical effect of aspirin on the growth of C6 rat glioma and on time of development of ENU-induced tumors of the nervous system. J. Cancer Res. Clin. Oncol 127: 681–686, https://doi.org/10.1007/s004320100267.Suche in Google Scholar PubMed

Arrieta, O., Guevara, P., Tamariz, J., Rembao, D., Rivera, E., and Sotelo, J. (2002). Antiproliferative effect of thalidomide alone and combined with carmustine against C6 rat glioma. Int. J. Exp. Pathol 83: 99–104, https://doi.org/10.1046/j.1365-2613.2002.00219.x.Suche in Google Scholar PubMed PubMed Central

Asai, A., Miyagi, Y., Sugiyama, A., Gamanuma, M., Hong, S.I., Takamoto, S., Nomura, K., Matsutani, M., Takakura, K., and Kuchino, Y. (1994). Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells: implication of the tumor suppressor genes for gene therapy. J. Neurooncol. 19: 259–268, https://doi.org/10.1007/bf01053280.Suche in Google Scholar PubMed

Assanah, M., Lochhead, R., Ogden, A., Bruce, J., Goldman, J., and Canoll, P. (2006). Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses. J. Neurosci. 26: 6781–6790, https://doi.org/10.1523/jneurosci.0514-06.2006.Suche in Google Scholar

Atzori, M.G., Tentori, L., Ruffini, F., Ceci, C., Bonanno, E., Scimeca, M., Lacal, P.M., and Graziani, G. (2018). The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits glioma growth and angiogenesis in vivo. J. Pharmacol. Exp. Ther. 364: 77–86, https://doi.org/10.1124/jpet.117.244434.Suche in Google Scholar PubMed

Auer, R.N., Maestro, R.F.D., and Anderson, R. (1981). A simple and reproducible experimental in vivo glioma model. Can J. Neurol. Sci. 8: 325–331, https://doi.org/10.1017/s0317167100043468.Suche in Google Scholar PubMed

Ayala-Domínguez, L., Pérez-Cárdenas, E., Avilés-Salas, A., Medina, L.A., Lizano, M., and Brandan, M.E. (2020). Quantitative imaging parameters of contrast-enhanced micro-computed tomography correlate with angiogenesis and necrosis in a subcutaneous C6 glioma model. Cancers 12: 3417, https://doi.org/10.3390/cancers12113417.Suche in Google Scholar PubMed PubMed Central

Ayers, G.D., McKinley, E.T., Zhao, P., Fritz, J.M., Metry, R.E., Deal, B.C., Adlerz, K.M., Coffey, R.J., and Manning, H.C. (2010). Volume of preclinical xenograft tumors is more accurately assessed by ultrasound imaging than manual caliper measurements. J. Ultrasound Med. 29: 891–901, https://doi.org/10.7863/jum.2010.29.6.891.Suche in Google Scholar PubMed PubMed Central

Barth, R.F. and Kaur, B. (2009). Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. J. Neurooncol. 94: 299–312, https://doi.org/10.1007/s11060-009-9875-7.Suche in Google Scholar PubMed PubMed Central

Benda, P., Lightbody, J., Sato, G., Levine, L., and Sweet, W. (1968). Differentiated rat glial cell strain in tissue culture. Science 161: 370–371, https://doi.org/10.1126/science.161.3839.370.Suche in Google Scholar PubMed

Bernstein, J.J., Goldberg, W.J., Laws, E.R.Jr., Conger, D., Morreale, V., and Wood, L.R. (1990). C6 glioma cell invasion and migration of rat brain after neural homografting: ultrastructure. Neurosurgery 26: 622–628, https://doi.org/10.1227/00006123-199004000-00010.Suche in Google Scholar

Beutler, A.S., Banck, M.S., Wedekind, D., and Hedrich, H.J. (1999). Tumor gene therapy made easy: allogeneic major histocompatibility complex in the C6 rat glioma model. Hum. Gene Ther. 10: 95–101, https://doi.org/10.1089/10430349950019228.Suche in Google Scholar PubMed

Biasibetti, E., Valazza, A., Capucchio, M.T., Annovazzi, L., Battaglia, L., Chirio, D., Gallarate, M., Mellai, M., Muntoni, E., Peira, E., et al.. (2017). Comparison of allogeneic and syngeneic rat glioma models by using MRI and histopathologic evaluation. Comp. Med. 67: 147–156.Suche in Google Scholar

Caballero Navarro, A., Conde Guerri, B., Sinues Porta, E., Boada Apilluelo, E., and Alcalá Arellano, A. (1992). In vitro analysis of the cellular resistance to chemotherapeutic BCNU. Histol. Histopathol. 7: 347–351.Suche in Google Scholar

Cai, W.-L. and Hong, G.-B. (2018). Quantitative image analysis for evaluation of tumor response in clinical oncology. Chronic Dis. Transl. Med. 4: 18–28, https://doi.org/10.1016/j.cdtm.2018.01.002.Suche in Google Scholar PubMed PubMed Central

Cao, M., Mao, J., Duan, X., Lu, L., Zhang, F., Lin, B., Chen, M., Zheng, C., Zhang, X., and Shen, J. (2018). In vivo tracking of the tropism of mesenchymal stem cells to malignant gliomas using reporter gene-based MR imaging. Int. J. Cancer 142: 1033–1046, https://doi.org/10.1002/ijc.31113.Suche in Google Scholar PubMed

Caragher, S., Chalmers, A.J., and Gomez-Roman, N. (2019). Glioblastoma’s next top model: novel culture systems for brain cancer radiotherapy research. Cancers 11: 44, https://doi.org/10.3390/cancers11010044.Suche in Google Scholar PubMed PubMed Central

Chintala, S.K., Tonn, J.C., and Rao, J.S. (1999). Matrix metalloproteinases and their biological function in human gliomas. Dev. Neurosci. 17: 495–502, https://doi.org/10.1016/s0736-5748(99)00010-6.Suche in Google Scholar PubMed

Chiu, K.M., Harris, J.E., Kroin, J.S., Slayton, W., and Braun, D.P. (1983). The immunological response of Wistar rats to the intracranially implanted C-6 glioma cell line. J. Neurooncol. 1: 365–372, https://doi.org/10.1007/bf00165720.Suche in Google Scholar PubMed

Coomber, B.L., Stewart, P.A., Hayakawa, E.M., Farrell, C.L., and Del Maestro, R.F. (1988). A quantitative assessment of microvessel ultrastructure in C6 astrocytoma spheroids transplanted to brain and to muscle. J. Neuropathol. Exp. Neurol. 47: 29–40, https://doi.org/10.1097/00005072-198801000-00004.Suche in Google Scholar PubMed

Dagıstan, Y., Karaca, I., Bozkurt, E.R., Ozar, E., Yagmurlu, K., Toklu, A., and Bilir, A. (2012). Combination hyperbaric oxygen and temozolomide therapy in C6 rat glioma model. Acta Cir. Bras. 27: 383–387, https://doi.org/10.1590/s0102-86502012000600005.Suche in Google Scholar PubMed

de Vasconcelos, A., de Moura, L.R., Pedra, N.S., Bona, N.P., Soares, M.S.P., da Silva Marques, M., Horn, A.P., Spohr, L., Spanevello, R.M., Stefanello, F.M., et al.. (2022). Thiazolidine-2,4-dione derivative exhibits antitumoral effect and reverts behavioral and metabolic changes in a model of glioblastoma. Metab. Brain. Dis. 37: 2053–2059, https://doi.org/10.1007/s11011-022-01005-5.Suche in Google Scholar PubMed

Doblas, S., He, T., Saunders, D., Pearson, J., Hoyle, J., Smith, N., Lerner, M., and Towner, R.A. (2010). Glioma morphology and tumor-induced vascular alterations revealed in seven rodent glioma models by in vivo magnetic resonance imaging and angiography. J. Magn. Reson. Imaging 32: 267–275, https://doi.org/10.1002/jmri.22263.Suche in Google Scholar PubMed PubMed Central

Du, Z., Jia, D., Liu, S., Wang, F., Li, G., Zhang, Y., Cao, X., Ling, E.A., and Hao, A.J.G. (2009). Oct4 is expressed in human gliomas and promotes colony formation in glioma cells. Glia 57: 724–733, https://doi.org/10.1002/glia.20800.Suche in Google Scholar PubMed

Fan, R., Chuan, D., Hou, H., Chen, H., Han, B., Zhang, X., Zhou, L., Tong, A., Xu, J., and Guo, G. (2019). Development of a hybrid nanocarrier-recognizing tumor vasculature and penetrating the BBB for glioblastoma multi-targeting therapy. Nanoscale 11: 11285–11304, https://doi.org/10.1039/c9nr01320b.Suche in Google Scholar PubMed

Fan, Y., Cui, Y., Hao, W., Chen, M., Liu, Q., Wang, Y., Yang, M., Li, Z., Gong, W., Song, S., et al.. (2021). Carrier-free highly drug-loaded biomimetic nanosuspensions encapsulated by cancer cell membrane based on homology and active targeting for the treatment of glioma. Bioact. Mater. 6: 4402–4414, https://doi.org/10.1016/j.bioactmat.2021.04.027.Suche in Google Scholar PubMed PubMed Central

Fratantonio, D., Molonia, M.S., Bashllari, R., Muscarà, C., Ferlazzo, G., Costa, G., Saija, A., Cimino, F., and Speciale, A. (2019). Curcumin potentiates the antitumor activity of Paclitaxel in rat glioma C6 cells. Phytomedicine 55: 23–30, https://doi.org/10.1016/j.phymed.2018.08.009.Suche in Google Scholar PubMed

Fridman, R., Benton, G., Aranoutova, I., Kleinman, H.K., and Bonfil, R.D. (2012). Increased initiation and growth of tumor cell lines, cancer stem cells and biopsy material in mice using basement membrane matrix protein (Cultrex or Matrigel) co-injection. Nat. Protoc. 7: 1138–1144, https://doi.org/10.1038/nprot.2012.053.Suche in Google Scholar PubMed

Fu, Y., Huang, R., Zheng, Y., Zhang, Z., and Liang, A. (2011). Glioma-derived mutations in isocitrate dehydrogenase 2 beneficial to traditional chemotherapy. Biochem. Biophys. Res. Commun. 410: 218–223, https://doi.org/10.1016/j.bbrc.2011.05.108.Suche in Google Scholar PubMed

Fu, Y., Zheng, Y., Li, K., Huang, R., Zheng, S., An, N., and Liang, A. (2012). Mutations in isocitrate dehydrogenase 2 accelerate glioma cell migration via matrix metalloproteinase-2 and 9. Biotechnol. Lett. 34: 441–446, https://doi.org/10.1007/s10529-011-0800-8.Suche in Google Scholar PubMed

Garcia, J.H., Jain, S., and Aghi, M.K. (2021). Metabolic drivers of invasion in glioblastoma. Front. Cell Dev. Biol. 9: 683276, https://doi.org/10.3389/fcell.2021.683276.Suche in Google Scholar PubMed PubMed Central

Giakoumettis, D., Kritis, A., and Foroglou, N. (2018). C6 cell line: the gold standard in glioma research. Hippokratia 22: 105–112.Suche in Google Scholar

Gieryng, A., Pszczolkowska, D., Bocian, K., Dabrowski, M., Rajan, W.D., Kloss, M., Mieczkowski, J., and Kaminska, B. (2017). Immune microenvironment of experimental rat C6 gliomas resembles human glioblastomas. Sci. Rep. 7: 17556, https://doi.org/10.1038/s41598-017-17752-w.Suche in Google Scholar PubMed PubMed Central

Glantz, M.J., Choy, H., Kearns, C.M., Mills, P.C., Wahlberg, L.U., Zuhowski, E.G., Calabresi, P., and Egorin, M.J. (1995). Paclitaxel disposition in plasma and central nervous systems of humans and rats with brain tumors. J. Natl. Cancer Inst. 87: 1077–1081, https://doi.org/10.1093/jnci/87.14.1077.Suche in Google Scholar PubMed

Grobben, B., De Deyn, P.P., and Slegers, H. (2002). Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cell Tissue Res. 310: 257–270, https://doi.org/10.1007/s00441-002-0651-7.Suche in Google Scholar PubMed

Guerin, E., Man, S., Xu, P., and Kerbel, R.S. (2013). A model of postsurgical advanced metastatic breast cancer more accurately replicates the clinical efficacy of antiangiogenic drugs. Cancer Res. 73: 2743–2748, https://doi.org/10.1158/0008-5472.can-12-4183.Suche in Google Scholar PubMed PubMed Central

Guevara, P. and Sotelo, J. (1999). C6 rat glioma grown into the peritoneal cavity, a large source of tumoral cells for subcutaneous transplant of glioma. J. Neurooncol. 44: 91–92, https://doi.org/10.1023/a:1006112422132.10.1023/A:1006112422132Suche in Google Scholar PubMed

Haddad, A.F., Young, J.S., Amara, D., Berger, M.S., Raleigh, D.R., Aghi, M.K., and Butowski, N.A. (2021). Mouse models of glioblastoma for the evaluation of novel therapeutic strategies. Neurooncol. Adv. 3: vdab100, https://doi.org/10.1093/noajnl/vdab100.Suche in Google Scholar PubMed PubMed Central

Han, S., Lee, Y., and Lee, M. (2021). Biomimetic cell membrane-coated DNA nanoparticles for gene delivery to glioblastoma. J. Control. Release 338: 22–32, https://doi.org/10.1016/j.jconrel.2021.08.021.Suche in Google Scholar PubMed

Haydar, N., Alyousef, K., Alanan, U., Issa, R., Baddour, F., Al-shehabi, Z., and Al-janabi, M.H. (2022). Role of Magnetic Resonance Imaging (MRI) in grading gliomas comparable with pathology: a cross-sectional study from Syria. Ann. Med. Surg 82: 104679, https://doi.org/10.1016/j.amsu.2022.104679.Suche in Google Scholar PubMed PubMed Central

Hetze, S., Sure, U., Schedlowski, M., Hadamitzky, M., and Barthel, L. (2021). Rodent models to analyze the glioma microenvironment. ASN Neuro. 13: 17590914211005074, https://doi.org/10.1177/17590914211005074.Suche in Google Scholar PubMed PubMed Central

Hirai, N., Watabe, T., Nagamori, S., Wiriyasermkul, P., Tanaka, Y., Romanov, V., Naka, S., Kanai, Y., Liu, Y., Tani, N., et al.. (2020). Evaluation of D-isomer of (18)F-FBPA for oncology PET focusing on the differentiation of glioma and inflammation. Asia Ocean J. Nucl. Med. Biol. 8: 102–108, https://doi.org/10.22038/AOJNMB.2020.47399.1321.Suche in Google Scholar PubMed PubMed Central

Hughes, C.S., Postovit, L.M., and Lajoie, G.A. (2010). Matrigel: a complex protein mixture required for optimal growth of cell culture. Proteomics 10: 1886–1890, https://doi.org/10.1002/pmic.200900758.Suche in Google Scholar PubMed

Hung, C.F. (2000). Effects of carmustine and lomustine on arylamine N-acetyltransferase activity and 2-aminofluorene-DNA adducts in rat glial tumor cells. Neurochem. Res. 25: 845–851, https://doi.org/10.1023/a:1007573609158.10.1023/A:1007573609158Suche in Google Scholar PubMed

Ireson, C.R., Alavijeh, M.S., Palmer, A.M., Fowler, E.R., and Jones, H.J. (2019). The role of mouse tumour models in the discovery and development of anticancer drugs. Br. J. Cancer 121: 101–108, https://doi.org/10.1038/s41416-019-0495-5.Suche in Google Scholar PubMed PubMed Central

Junttila, M.R. and de Sauvage, F.J. (2013). Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 501: 346–354, https://doi.org/10.1038/nature12626.Suche in Google Scholar PubMed

Kato, H., Huang, X., Kadonaga, Y., Katayama, D., Ooe, K., Shimoyama, A., Kabayama, K., Toyoshima, A., Shinohara, A., Hatazawa, J., et al.. (2021). Intratumoral administration of astatine-211-labeled gold nanoparticle for alpha therapy. J. Nanobiotechnol. 19: 223, https://doi.org/10.1186/s12951-021-00963-9.Suche in Google Scholar PubMed PubMed Central

Kaye, A.H., Morstyn, G., Gardner, I., and Pyke, K. (1986). Development of a xenograft glioma model in mouse brain. Cancer Res. 46: 1367–1373.Suche in Google Scholar

Kefayat, A., Ghahremani, F., Motaghi, H., and Amouheidari, A. (2019). Ultra-small but ultra-effective: folic acid-targeted gold nanoclusters for enhancement of intracranial glioma tumors’ radiation therapy efficacy. Nanomedicine 16: 173–184, https://doi.org/10.1016/j.nano.2018.12.007.Suche in Google Scholar PubMed

Kim, J., Lee, J.W., Kim, S.I., Choi, Y.J., Lee, W.K., Jeong, M.J., Cha, S.H., Lee, H.J., Chun, W., and Kim, S.S. (2011). Thrombin-induced migration and matrix metalloproteinase-9 expression are regulated by MAPK and PI3K pathways in C6 glioma cells. Korean J. Physiol. Pharmacol. 15: 211–216, https://doi.org/10.4196/kjpp.2011.15.4.211.Suche in Google Scholar PubMed PubMed Central

Knüpfer, M.M., Poppenborg, H., Hotfilder, M., Kühnel, K., Wolff, J.E., and Domula, M. (1999). CD44 expression and hyaluronic acid binding of malignant glioma cells. Clin. Exp. Metastasis 17: 71–76, https://doi.org/10.1023/a:1026425519497.10.1023/A:1026425519497Suche in Google Scholar PubMed

Kodera, T., Nakagawa, T., Kubota, T., Kabuto, M., Sato, K., and Kobayashi, H. (2000). The expression and activation of matrix metalloproteinase-2 in rat brain after implantation of C6 rat glioma cells. J. Neurooncol. 46: 105–114, https://doi.org/10.1023/a:1006387600909.10.1023/A:1006387600909Suche in Google Scholar

Kondo, T., Setoguchi, T., and Taga, T. (2004). Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc. Natl. Acad. Sci. U.S.A. 101: 781–786, https://doi.org/10.1073/pnas.0307618100.Suche in Google Scholar PubMed PubMed Central

Lemasson, B., Valable, S., Farion, R., Krainik, A., Rémy, C., and Barbier, E.L. (2013). In vivo imaging of vessel diameter, size, and density: a comparative study between MRI and histology. Magn. Reson. Med. 69: 18–26, https://doi.org/10.1002/mrm.24218.Suche in Google Scholar PubMed

Li, J.H., Li, S.Y., Shen, M.X., Qiu, R.Z., Fan, H.W., and Li, Y.B. (2021). Anti-tumor effects of Solanum nigrum L. extraction on C6 high-grade glioma. J. Ethnopharmacol. 274: 114034, https://doi.org/10.1016/j.jep.2021.114034.Suche in Google Scholar PubMed

Li, Q., Qiao, G., Ma, J., and Li, Y. (2014). Downregulation of VEGF expression attenuates malignant biological behavior of C6 glioma stem cells. Int. J. Oncol. 44: 1581–1588, https://doi.org/10.3892/ijo.2014.2331.Suche in Google Scholar PubMed

Li, S., Li, J., Fan, Y., Huang, T., Zhou, Y., Fan, H., Zhang, Q., and Qiu, R. (2022). The mechanism of formononetin/calycosin compound optimizing the effects of temozolomide on C6 malignant glioma based on metabolomics and network pharmacology. Biomed. Pharmacother 153: 113418, https://doi.org/10.1016/j.biopha.2022.113418.Suche in Google Scholar PubMed

Lin, X.-M., Shi, X.-X., Xiong, L., Nie, J.-H., Ye, H.-S., Du, J.-Z., and Liu, J.J.I.J.o.M.S. (2021). Construction of IL-13 receptor α2-targeting resveratrol nanoparticles against glioblastoma cells: therapeutic efficacy and molecular effects. Int. J. Mol. Sci. 22: 10622, https://doi.org/10.3390/ijms221910622.Suche in Google Scholar PubMed PubMed Central

Liu, J., Zhou, J., Li, J., Zhang, L., Zhang, P., and Liu, B. (2017). Evaluation of rat C6 malignant glioma using spectral computed tomography. Exp. Ther. Med. 14: 1037–1044, https://doi.org/10.3892/etm.2017.4613.Suche in Google Scholar PubMed PubMed Central

Liu, Q., Zhou, L., Lu, R., Yang, C., Wang, S., Hai, L., and Wu, Y. (2021). Biotin and glucose co-modified multi-targeting liposomes for efficient delivery of chemotherapeutics for the treatment of glioma. Bioorg. Med. Chem. 29: 115852, https://doi.org/10.1016/j.bmc.2020.115852.Suche in Google Scholar PubMed

Low, J.T., Ostrom, Q.T., Cioffi, G., Neff, C., Waite, K.A., Kruchko, C., and Barnholtz-Sloan, J.S. (2022). Primary brain and other central nervous system tumors in the United States (2014–2018): a summary of the CBTRUS statistical report for clinicians. Neurooncol. Pract. 9: 165–182, https://doi.org/10.1093/nop/npac015.Suche in Google Scholar PubMed PubMed Central

Maire, C.L. and Ligon, K.L. (2014). Molecular pathologic diagnosis of epidermal growth factor receptor. Neuro Oncol. 16: viii1–6, https://doi.org/10.1093/neuonc/nou294.Suche in Google Scholar PubMed PubMed Central

Manju, C.A., Jeena, K., Ramachandran, R., Manohar, M., Ambily, A.M., Sajesh, K.M., Gowd, G.S., Menon, K., Pavithran, K., Pillai, A., et al.. (2021). Intracranially injectable multi-siRNA nanomedicine for the inhibition of glioma stem cells. Neurooncol. Adv. 3: vdab104, https://doi.org/10.1093/noajnl/vdab104.Suche in Google Scholar PubMed PubMed Central

Masuda, J., Takayama, E., Strober, W., Satoh, A., Morimoto, Y., Honjo, Y., Ichinohe, T., Tokuno, S.-I., Ishizuka, T., Nakata, T., et al.. (2017). Tumor growth limited to subcutaneous site vs tumor growth in pulmonary site exhibit differential effects on systemic immunities. Oncol. Rep. 38: 449–455, https://doi.org/10.3892/or.2017.5646.Suche in Google Scholar PubMed PubMed Central

Mayas, M.D., Ramírez-Expósito, M.J., Carrera, M.P., Cobo, M., and Martínez-Martos, J.M. (2012). Renin-angiotensin system-regulating aminopeptidases in tumor growth of rat C6 gliomas implanted at the subcutaneous region. Anticancer Res. 32: 3675–3682.Suche in Google Scholar

Mayer, J., Kirschstein, T., Resch, T., Porath, K., Krause, B.J., Köhling, R., and Lange, F. (2020). Perampanel attenuates epileptiform phenotype in C6 glioma. Neurosci. Lett. 715: 134629, https://doi.org/10.1016/j.neulet.2019.134629.Suche in Google Scholar PubMed

Miura, F.K., Alves, M.J.F., Rocha, M.C., Silva, R.S., Oba-Shinjo, S.M., Uno, M., Colin, C., Sogayar, M.C., and Marie, S.K.J.A.d.n.-p. (2008). Experimental model of C6 brain tumors in athymic rats. Arq. Neuro. Psiquiatr. 66: 238–241, https://doi.org/10.1590/s0004-282x2008000200019.Suche in Google Scholar PubMed

Mohammed, S., Dinesan, M., and Ajayakumar, T. (2022). Survival and quality of life analysis in glioblastoma multiforme with adjuvant chemoradiotherapy: a retrospective study. Rep. Pract. Oncol. Radiother 27: 1026–1036, https://doi.org/10.5603/rpor.a2022.0113.Suche in Google Scholar

Murgoci, A.N., Cardon, T., Aboulouard, S., Duhamel, M., Fournier, I., Cizkova, D., and Salzet, M. (2020). Reference and ghost proteins identification in rat C6 glioma extracellular vesicles. iScience 23: 101045, https://doi.org/10.1016/j.isci.2020.101045.Suche in Google Scholar PubMed PubMed Central

Nagano, N., Sasaki, H., Aoyagi, M., and Hirakawa, K. (1993). Invasion of experimental rat brain tumor: early morphological changes following microinjection of C6 glioma cells. Acta Neuropathol. 86: 117–125, https://doi.org/10.1007/bf00334878.Suche in Google Scholar

Oh, T., Fakurnejad, S., Sayegh, E.T., Clark, A.J., Ivan, M.E., Sun, M.Z., Safaee, M., Bloch, O., James, C.D., and Parsa, A.T. (2014). Immunocompetent murine models for the study of glioblastoma immunotherapy. J. Transl. Med. 12: 107, https://doi.org/10.1186/1479-5876-12-107.Suche in Google Scholar PubMed PubMed Central

Orozco-Morales, M., Sánchez-García, F.-J., Guevara-Salazar, P., Arrieta, O., Hernández-Pedro, N.Y., Sánchez-García, A., Perez-Madrigal, R., Rangel-López, E., Pineda, B., and Sotelo, J. (2012). Adjuvant immunotherapy of C6 glioma in rats with pertussis toxin. J. Cancer Res. Clin. Oncol. 138: 23–33, https://doi.org/10.1007/s00432-011-1069-y.Suche in Google Scholar PubMed

Ostrom, Q.T., Gittleman, H., Truitt, G., Boscia, A., Kruchko, C., and Barnholtz-Sloan, J.S. (2018). CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011–2015. Neuro Oncol. 20: iv1–iv86, https://doi.org/10.1093/neuonc/noy131.Suche in Google Scholar PubMed PubMed Central

Parsa, A.T., Chakrabarti, I., Hurley, P.T., Chi, J.H., Hall, J.S., Kaiser, M.G., and Bruce, J.N. (2000). Limitations of the C6/Wistar rat intracerebral glioma model: implications for evaluating immunotherapy. Neurosurgery 47: 993–999; discussion 999–1000, https://doi.org/10.1097/00006123-200010000-00050.Suche in Google Scholar PubMed

Pigula, M., Huang, H.C., Mallidi, S., Anbil, S., Liu, J., Mai, Z., and Hasan, T. (2019). Size-dependent tumor response to photodynamic therapy and irinotecan monotherapies revealed by longitudinal ultrasound monitoring in an orthotopic pancreatic cancer model. Photochem. Photobiol. 95: 378–386, https://doi.org/10.1111/php.13016.Suche in Google Scholar PubMed PubMed Central

Pineda, B., Sánchez García, F.J., Olascoaga, N.K., Pérez de la Cruz, V., Salazar, A., Moreno-Jiménez, S., Hernández Pedro, N., Márquez-Navarro, A., Ortiz Plata, A., and Sotelo, J. (2019). Malignant glioma therapy by vaccination with irradiated C6 cell-derived microvesicles promotes an antitumoral immune response. Mol. Ther. 27: 1612–1620, https://doi.org/10.1016/j.ymthe.2019.05.016.Suche in Google Scholar PubMed PubMed Central

Plate, K.H., Breier, G., Millauer, B., Ullrich, A., and Risau, W. (1993). Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res. 53: 5822–5827.Suche in Google Scholar

Pombo Antunes, A.R., Scheyltjens, I., Duerinck, J., Neyns, B., Movahedi, K., and Van Ginderachter, J.A. (2020). Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies. eLife 9: 52176, https://doi.org/10.7554/elife.52176.Suche in Google Scholar PubMed PubMed Central

Poon, M.T.C., Sudlow, C.L.M., Figueroa, J.D., and Brennan, P.M. (2020). Longer-term (≥ 2 years) survival in patients with glioblastoma in population-based studies pre-and post-2005: a systematic review and meta-analysis. Sci. Rep. 10: 11622, https://doi.org/10.1038/s41598-020-68011-4.Suche in Google Scholar PubMed PubMed Central

Pu, P., Liu, X., Liu, A., Cui, J., and Zhang, Y. (2000). Inhibitory effect of antisense epidermal growth factor receptor RNA on the proliferation of rat C6 glioma cells in vitro and in vivo. J. Neurosurg. 92: 132–139, https://doi.org/10.3171/jns.2000.92.1.0132.Suche in Google Scholar PubMed

Reyes, S., Herrera, L.A., Ostrosky, P., and Sotelo, J.J.N. (2001). Quinacrine enhances carmustine therapy of experimental rat glioma. Neurosurgery 49: 969–973, https://doi.org/10.1097/00006123-200110000-00033.Suche in Google Scholar PubMed

Rivera, E., Arrieta, O., Guevara, P., Duarte-Rojo, A., and Sotelo, J. (2001). AT1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma. Br. J. Cancer 85: 1396–1399, https://doi.org/10.1054/bjoc.2001.2102.Suche in Google Scholar PubMed PubMed Central

Sahu, U., Barth, R.F., Otani, Y., McCormack, R., and Kaur, B. (2022). Rat and mouse brain tumor models for experimental neuro-oncology research. J. Neuropathol. Exp. Neurol. 81: 312–329, https://doi.org/10.1093/jnen/nlac021.Suche in Google Scholar PubMed PubMed Central

Sajjad, H., Imtiaz, S., Noor, T., Siddiqui, Y.H., Sajjad, A., and Zia, M. (2021). Cancer models in preclinical research: a chronicle review of advancement in effective cancer research. Animal Model Exp. Med. 4: 87–103, https://doi.org/10.1002/ame2.12165.Suche in Google Scholar PubMed PubMed Central

Saleh, M., Stacker, S.A., and Wilks, A.F. (1996). Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res. 56: 393–401.Suche in Google Scholar

Samani, A.A., Nalbantoglu, J., and Brodt, P. (2020). Glioma cells with genetically engineered IGF-I receptor downregulation can persist in the brain in a dormant State. Front. Oncol. 10: 555945, https://doi.org/10.3389/fonc.2020.555945.Suche in Google Scholar PubMed PubMed Central

Schlegel, J., Piontek, G., Kersting, M., Schuermann, M., Kappler, R., Scherthan, H., Weghorst, C., Buzard, G., and Mennel, H. (1999). The p16/Cdkn2a/Ink4a gene is frequently deleted in nitrosourea-induced rat glial tumors. Pathobiology 67: 202–206, https://doi.org/10.1159/000028073.Suche in Google Scholar PubMed

Schmidek, H.H., Nielsen, S.L., Schiller, A.L., and Messer, J. (1971). Morphological studies of rat brain tumors induced by N-nitrosomethylurea. J. Neurosurg. 34: 335–340, https://doi.org/10.3171/jns.1971.34.3.0335.Suche in Google Scholar PubMed

Sharifzad, F., Yasavoli-Sharahi, H., Mardpour, S., Fakharian, E., Nikuinejad, H., Heydari, Y., Mardpour, S., Taghikhani, A., Khellat, R., Vafaei, S., et al.. (2019). Neuropathological and genomic characterization of glioblastoma-induced rat model: how similar is it to humans for targeted therapy? J. Cell. Physiol. 234: 22493–22504, https://doi.org/10.1002/jcp.28813.Suche in Google Scholar PubMed

Shi, J., Zhang, Y., Fu, W.M., Chen, M., and Qiu, Z. (2015). Establishment of C6 brain glioma models through stereotactic technique for laser interstitial thermotherapy research. Surg. Neurol. Int. 6: 51, https://doi.org/10.4103/2152-7806.154451.Suche in Google Scholar PubMed PubMed Central

Sibenaller, Z.A., Etame, A.B., Ali, M.M., Barua, M., Braun, T.A., Casavant, T.L., and Ryken, T.C. (2005). Genetic characterization of commonly used glioma cell lines in the rat animal model system. Neurosurg. Focus 19: E1, https://doi.org/10.3171/foc.2005.19.4.2.Suche in Google Scholar PubMed

Singh, D., Dromel, P.C., Perepelkina, T., Baranov, P., and Young, M. (2020). C6 cell injection into the optic nerve of long-evans rats: a short-term model of optic pathway gliomas. Cell Transplant. 29: 963689720964383, https://doi.org/10.1177/0963689720964383.Suche in Google Scholar PubMed PubMed Central

Singh, N., Miner, A., Hennis, L., and Mittal, S. (2021). Mechanisms of temozolomide resistance in glioblastoma – a comprehensive review. Cancer Drug Resist. 4: 17–43, https://doi.org/10.20517/cdr.2020.79.Suche in Google Scholar PubMed PubMed Central

Slavkova, K.P., Patel, S.H., Cacini, Z., Kazerouni, A.S., Gardner, A.L., Yankeelov, T.E., and Hormuth, D.A. (2023). Mathematical modelling of the dynamics of image-informed tumor habitats in a murine model of glioma. Sci. Rep. 13: 2916, https://doi.org/10.1038/s41598-023-30010-6.Suche in Google Scholar PubMed PubMed Central

Song, T.-W., Lee, J.-K., Lee, S.-Y., Lian, S., Joo, S.-P., and Kim, H.-S.J.T.N. (2016). Establishment of a malignant glioma model in rats. The Nerve 2: 17–21, https://doi.org/10.21129/nerve.2016.2.2.17.Suche in Google Scholar

Stribbling, S.M. and Ryan, A.J. (2022). The cell-line-derived subcutaneous tumor model in preclinical cancer research. Nat. Protoc. 17: 2108–2128, https://doi.org/10.1038/s41596-022-00709-3.Suche in Google Scholar PubMed

Taheri, B., Soleimani, M., Aval, S.F., Memari, F., and Zarghami, N. (2018). C6 glioma-derived microvesicles stimulate the proliferative and metastatic gene expression of normal astrocytes. Neurosci. Lett. 685: 173–178, https://doi.org/10.1016/j.neulet.2018.08.034.Suche in Google Scholar PubMed

Tan, X., Kim, G., Lee, D., Oh, J., Kim, M., Piao, C., Lee, J., Lee, M.S., Jeong, J.H., and Lee, M. (2018). A curcumin-loaded polymeric micelle as a carrier of a microRNA-21 antisense-oligonucleotide for enhanced anti-tumor effects in a glioblastoma animal model. Biomater. Sci. 6: 407–417, https://doi.org/10.1039/c7bm01088e.Suche in Google Scholar PubMed

Tankov, S. and Walker, P.R. (2021). Glioma-derived extracellular vesicles – far more than local mediators. Front. Immunol. 12: 679954, https://doi.org/10.3389/fimmu.2021.679954.Suche in Google Scholar PubMed PubMed Central

Tao, J., Fei, W., Tang, H., Li, C., Mu, C., Zheng, H., Li, F., and Zhu, Z. (2019). Angiopep-2-conjugated “Core-Shell” hybrid nanovehicles for targeted and pH-triggered delivery of arsenic trioxide into glioma. Mol. Pharm. 16: 786–797, https://doi.org/10.1021/acs.molpharmaceut.8b01056.Suche in Google Scholar PubMed

Taylor, M.A., Hughes, A.M., Walton, J., Coenen-Stass, A.M.L., Magiera, L., Mooney, L., Bell, S., Staniszewska, A.D., Sandin, L.C., Barry, S.T., et al.. (2019). Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery. J. Immunother Cancer 7: 328, https://doi.org/10.1186/s40425-019-0794-7.Suche in Google Scholar PubMed PubMed Central

Trejo-Solís, C., Palencia, G., Zuñiga, S., Rodríguez-Ropon, A., Osorio-Rico, L., Torres Luvia, S., Gracia-Mora, I., Marquez-Rosado, L., Sánchez, A., Moreno-García, M.E., et al.. (2005). Cas ilgly induces apoptosis in glioma C6 cells in vitro and in vivo through caspase-dependent and caspase-independent mechanisms. Neoplasia 7: 563–574, https://doi.org/10.1593/neo.04607.Suche in Google Scholar PubMed PubMed Central

Turna, A., Kıran, B., Ozar, E., Turna, H., Mercan, C.A., Büyükpınarbaşılı, N., Bilir, A., and Deniz, G.J.T.J.o.I. (2013). Interleukin-12 and protamine inhibit angiogenesis and growth of C6 rat glioma: synergistic effects and role of Th2 cells. Turk. J. Immunol. 1: 68–73, https://doi.org/10.5606/tji.2013.268.Suche in Google Scholar

Tzerkovsky, D.A., Osharin, V.V., Istomin, Y.P., Alexandrova, E.N., and Vozmitel, M.A. (2014). Fluorescent diagnosis and photodynamic therapy for C6 glioma in combination with antiangiogenic therapy in subcutaneous and intracranial tumor models. Exp. Oncol. 36: 85–89.Suche in Google Scholar

Varna, M., Bertheau, P., and Legrès, L.G.J.J.o.A.O. (2014). Tumor microenvironment in human tumor xenografted mouse models. J. Anal. Oncol. 3: 159–166.10.6000/1927-7229.2014.03.03.6Suche in Google Scholar

Vinores, S.A. and Koestner, A. (1981). Effect of nerve growth factor producing cells on anaplastic glioma and pheochromocytoma clones: involvement of other factors. J. Neurosci. Res. 6: 389–401, https://doi.org/10.1002/jnr.490060314.Suche in Google Scholar PubMed

Wang, D., Lu, Y., Li, X., Mei, N., Wu, P.Y., Geng, D., Wu, H., and Yin, B. (2022). Evaluation of HIF-1α expression in a rat glioma model using intravoxel incoherent motion and R2* mapping. Front. Oncol. 12: 902612, https://doi.org/10.3389/fonc.2022.902612.Suche in Google Scholar PubMed PubMed Central

Watabe, T., Ikeda, H., Nagamori, S., Wiriyasermkul, P., Tanaka, Y., Naka, S., Kanai, Y., Hagiwara, K., Aoki, M., Shimosegawa, E., et al.. (2017). (18)F-FBPA as a tumor-specific probe of L-type amino acid transporter 1 (LAT1): a comparison study with (18)F-FDG and (11)C-Methionine PET. Eur. J. Nucl. Med. Mol. Imaging 44: 321–331, https://doi.org/10.1007/s00259-016-3487-1.Suche in Google Scholar PubMed

Watanabe, K., Sakamoto, M., Somiya, M., Amin, M.R., Kamitani, H., and Watanabe, T. (2002). Feasibility and limitations of the rat model by C6 gliomas implanted at the subcutaneous region. Neurol. Res. 24: 485–490, https://doi.org/10.1179/016164102101200221.Suche in Google Scholar PubMed

Woroniecka, K., Chongsathidkiet, P., Rhodin, K., Kemeny, H., Dechant, C., Farber, S.H., Elsamadicy, A.A., Cui, X., Koyama, S., Jackson, C., et al.. (2018). T-cell exhaustion signatures vary with tumor type and are severe in glioblastoma. Clin. Cancer Res. 24: 4175–4186, https://doi.org/10.1158/1078-0432.ccr-17-1846.Suche in Google Scholar PubMed PubMed Central

Wu, H., Wang, C., Liu, J., Zhou, D., Chen, D., Liu, Z., Wu, A., Yang, L., Chang, J., Luo, C., et al.. (2020). Evaluation of a tumor electric field treatment system in a rat model of glioma. CNS Neurosci. Ther. 26: 1168–1177, https://doi.org/10.1111/cns.13441.Suche in Google Scholar PubMed PubMed Central

Wu, L., Li, Q., Deng, J., Shen, J., Xu, W., Yang, W., Chen, B., Du, Y., Zhang, W., Ge, F.J.I.J.o. N., et al.. (2021). Platelet-tumor cell hybrid membrane-camouflaged nanoparticles for enhancing therapy efficacy in glioma. Int. J. Nanomedicine 16: 8433, https://doi.org/10.2147/ijn.s333279.Suche in Google Scholar

Wu, S.K., Santos, M.A., Marcus, S.L., and Hynynen, K. (2019). MR-guided focused ultrasound facilitates sonodynamic therapy with 5-aminolevulinic acid in a rat glioma model. Sci. Rep. 9: 10465, https://doi.org/10.1038/s41598-019-46832-2.Suche in Google Scholar PubMed PubMed Central

Xiong, J., Zhou, L., Lim, Y., Yang, M., Zhu, Y.-H., Li, Z.-W., Zhou, F.H., Xiao, Z.-C., and Zhou, X.-F. (2013). Mature BDNF promotes the growth of glioma cells in vitro. Oncol. Rep. 30: 2719–2724, https://doi.org/10.3892/or.2013.2746.Suche in Google Scholar PubMed

Xu, C.S., Wang, Z.F., Dai, L.M., Chu, S.H., Gong, L.L., Yang, M.H., and Li, Z.Q. (2014). Induction of proline-rich tyrosine kinase 2 activation-mediated C6 glioma cell invasion after anti-vascular endothelial growth factor therapy. J. Transl. Med. 12: 148, https://doi.org/10.1186/1479-5876-12-148.Suche in Google Scholar PubMed PubMed Central

Xu, Y., Yang, X., Mei, S., Sun, Y., and Li, J. (2019). Acquisition of temozolomide resistance by the rat C6 glioma cell line increases cell migration and side population phenotype. Oncol. Rep. 42: 2355–2362, https://doi.org/10.3892/or.2019.7350.Suche in Google Scholar PubMed PubMed Central

Yan, G., Yi, M., Li, S., Yang, L., Dai, Z., Xuan, Y., and Wu, R. (2021). Quantitative metabolic characteristics in the peritumoral region of gliomas at 7T. Technol. Health Care 29: 509–517, https://doi.org/10.3233/thc-218048.Suche in Google Scholar

Yang, C., Xia, Z., Li, T., Chen, Y., Zhao, M., Sun, Y., Ma, J., Wu, Y., Wang, X., Wang, P., et al.. (2020a). Antioxidant effect of propofol in gliomas and its association with divalent metal transporter 1. Front. Oncol. 10: 590931, https://doi.org/10.3389/fonc.2020.590931.Suche in Google Scholar PubMed PubMed Central

Yang, H., Chen, W., Ma, J., Zhao, J., Li, D., Cao, Y., and Liu, P. (2020b). Silver nanotriangles and chemotherapeutics synergistically induce apoptosis in glioma cells via a ROS-dependent mitochondrial pathway. Int. J. Nanomed. 15: 7791–7803, https://doi.org/10.2147/ijn.s267120.Suche in Google Scholar PubMed PubMed Central

Yang, L., Lin, Z., Huang, Q., Lin, J., Chen, Z., Zhou, L., and Zhang, P. (2011). Effect of vascular endothelial growth factor on remodeling of C6 glioma tissue in vivo. J. Neurooncol. 103: 33–41, https://doi.org/10.1007/s11060-010-0356-9.Suche in Google Scholar PubMed

Yang, W.-H., Cheng, C.-Y., Chen, M.-F., and Wang, T.-C.J.A.R. (2018). Cell subpopulations overexpressing p75NTR have tumor-initiating properties in the C6 glioma cell line. Anticancer Res. 38: 5183–5192, https://doi.org/10.21873/anticanres.12841.Suche in Google Scholar PubMed

Yao, N.-W., Chang, C., Lin, H.-T., Yen, C.-T., and Chen, J.-Y.J.S.R. (2016). Functional assessment of glioma pathogenesis by in vivo multi-parametric magnetic resonance imaging and in vitro analyses. Sci. Rep. 6: 1–12, https://doi.org/10.1038/srep26050.Suche in Google Scholar PubMed PubMed Central

Yao, Q., Cai, G., Yu, Q., Shen, J., Gu, Z., Chen, J., Shi, W., and Shi, J. (2018). IDH1 mutation diminishes aggressive phenotype in glioma stem cells. Int. J. Oncol. 52: 270–278, https://doi.org/10.3892/ijo.2017.4186.Suche in Google Scholar PubMed

Yi, N., Oh, B., Kim, H.A., and Lee, M. (2014). Combined delivery of BCNU and VEGF siRNA using amphiphilic peptides for glioblastoma. J. Drug Target. 22: 156–164, https://doi.org/10.3109/1061186x.2013.850502.Suche in Google Scholar PubMed

Yin, W., Zhang, K., Deng, Q., Yu, Q., Mao, Y., Zhao, R., and Ma, S. (2021). AZD3759 inhibits glioma through the blockade of the epidermal growth factor receptor and Janus kinase pathways. Bioengineered 12: 8679–8689, https://doi.org/10.1080/21655979.2021.1991160.Suche in Google Scholar PubMed PubMed Central

Zhou, X., Wang, X., Qu, F., Zhong, Y., Lu, X., Zhao, P., Wang, D., Huang, Q., Zhang, L., and Li, X.J.J.o. I.M.R. (2009). Detection of cancer stem cells from the C6 glioma cell line. J Int Med Res 37: 503–510, https://doi.org/10.1177/147323000903700226.Suche in Google Scholar PubMed

Zhu, J., Zhang, Y., Chen, X., Zhang, Y., Zhang, K., Zheng, H., Wei, Y., Zheng, H., Zhu, J., Wu, F., et al.. (2021). Angiopep-2 modified lipid-coated mesoporous silica nanoparticles for glioma targeting therapy overcoming BBB. Biochem. Biophys. Res. Commun. 534: 902–907, https://doi.org/10.1016/j.bbrc.2020.10.076.Suche in Google Scholar PubMed